FundingWatcher
Home / Investors / Corporate venture capital / DACH

Corporate venture capital in DACH

Updated 16 Nov 2026

Reset

Venture funds

4 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix.
Ingelheim Am Rhein, Germany
Biotech, Health care Seed, Early stage venture 47% 4
2 Hitachi Ventures
Hitachi Ventures is the global venture capital arm of Hitachi Group, with recent investments in Thea Energy and Archetype AI.
Munich, Germany
Artificial intelligence, Biotech Early stage venture 19% 2
3 Leaps by Bayer
Leaps by Bayer invests in biotechnology, agriculture and scientific breakthroughs, with recent investments in 9amHealth and CORXEL Pharmaceuticals.
Leverkusen, Germany
Health care, Biotech Early stage venture 40% 2
4 Novartis Venture Fund
Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics.
Basel, Switzerland
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 2

Table 1. Corporate venture capital in DACH: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Corporate venture capital in DACH
One-time CSV
  • 124 firms, 120 with a website
  • 83 firm email addresses
  • 60 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-corporate-venture-capital-dach.csv124 rows × 15 columns
InvestorTypeLocationEmailPhone
Novartis Venture FundCorporate venture armBasel, Switzerland•••@sosei.com877 28•••
Bosch VenturesCorporate venture armStuttgart, Germany•••@de.bosch.com+49 71•••
UBSCorporate venture armZürich, Switzerland•••@ubs.com41 44 •••
Roche Venture FundCorporate venture armBasel, Switzerland•••@roche.com
SevenVenturesCorporate venture armUnterföhring, Germany•••@sevenventures.de
NeosferCorporate venture armFrankfurt, Germany•••@neosfer.com+49 69•••
EnBW New VenturesCorporate venture armKarlsruhe, Germany•••@env.vc
Ringier Digital VenturesCorporate venture armZürich, Switzerland•••@ringierdigital.ch

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

124
Investors
83
With email
60
With phone
17
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Corporate venture capital in DACH

30 of 124, most investments first
30 rows
# Investor Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Novartis Venture Fund Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
2 Bosch Ventures Stuttgart, Germany Hardware, Artificial intelligence Point2 Technology 1 160 44 32 •••@de.bosch.com +49 71••• In the CSV
3 UBS Zürich, Switzerland Fintech, Hardware SWISSto12, MerQube, Nasdaq Private Market 3 157 53 53 •••@ubs.com 41 44 ••• In the CSV
4 Roche Venture Fund Basel, Switzerland Health care, Biotech Cour Pharmaceuticals Development 1 121 15 41 •••@roche.com In the CSV
5 Leaps by Bayer Leverkusen, Germany Health care, Biotech 9amHealth, CORXEL Pharmaceuticals 2 113 45 13 In the CSV
6 Boehringer Ingelheim Venture Fund Ingelheim Am Rhein, Germany Biotech, Health care smartbax, xCures, Tacalyx 4 99 47 12 +49 61•••
7 BASF Venture Capital Ludwigshafen, Germany Biotech, Artificial intelligence Computomics 1 88 35 18 973 24••• In the CSV
8 ABB Ventures Zürich, Switzerland Artificial intelligence, Hardware Sevensense Robotics, Enervalis, Numocity 68 29 12 In the CSV
9 Porsche Ventures Stuttgart, Germany Fintech, Hardware KeySavvy, Retorio, INTAMSYS 68 18 7 In the CSV
10 Hitachi Ventures Munich, Germany Artificial intelligence, Biotech Thea Energy, Archetype AI 2 68 13 3 In the CSV
11 SevenVentures Unterföhring, Germany Commerce, Fintech presono, mybacs, BeautyLove 64 14 17 •••@sevenventures.de In the CSV
12 Neosfer Frankfurt, Germany Fintech, Artificial intelligence Vamo, Fairown, Bling.de 56 14 9 •••@neosfer.com +49 69••• In the CSV
13 LBBW VC Stuttgart, Germany Biotech, Health care Exciva 1 47 14 7 +49 71••• In the CSV
14 Siemens Financial Services Munich, Germany Energy, Hardware Carbyon, FertigHy 42 10 14 +49 (8••• In the CSV
15 EnBW New Ventures Karlsruhe, Germany Energy, Hardware enspired, Sunhat, Cozero 41 17 6 •••@env.vc In the CSV
16 Evonik Venture Capital Hanau, Germany Artificial intelligence, Hardware Velox, HPNow, Castor Technologies LTD 35 15 5 +49 20••• In the CSV
17 dRx Capital Basel, Switzerland Biotech, Health care Dopavision 31 4 8 In the CSV
18 SIX FinTech Ventures Zürich, Switzerland Fintech, Artificial intelligence Relio, Coinfirm, PXL Vision 30 13 2 +41 58••• In the CSV
19 Ringier Digital Ventures Zürich, Switzerland Commerce, Health care yamo, Archilyse AG, ABOUT YOU 30 10 14 •••@ringierdigital.ch In the CSV
20 Axel Springer Digital Ventures Berlin, Germany Artificial intelligence, Commerce Fineway, Familynet GmbH, Blendle 28 6 10 •••@axelspringer.de In the CSV
21 Swiss Post Ventures Bern, Switzerland Commerce, Hardware Classtime, CareerFairy, awork 28 4 4
22 Elevator Ventures Vienna, Austria Fintech, Commerce FINQware, SESAMm, Autenti 27 14 4 •••@elevator-ventures.com (650) ••• In the CSV
23 TRUMPF Venture Ditzingen, Germany Artificial intelligence, Cybersecurity Quside, Peers Solutions, ammune.ai 27 12 4 •••@trumpf.com In the CSV
24 Bertelsmann Investments Gütersloh, Germany Health care, Artificial intelligence QuantHealth 1 24 3 2 •••@bertelsmann.de 490-52••• In the CSV
25 Best Nights VC Berlin, Germany 22 0 1 •••@bestnights.vc In the CSV
26 Porsche Stuttgart, Germany Hardware, Fintech Bluedot, Sensigo, INTAMSYS 21 5 3 •••@gmail.com In the CSV
27 Berliner Volksbank Ventures Berlin, Germany Fintech, Commerce Qwist, VAI Trade, Inventorum 20 5 5 •••@volksbank-ventures.berlin 030 30••• In the CSV
28 pd ventures Augsburg, Germany Software Ryte, DS Digitale Seiten 20 3 9 •••@pdventures.de +49 82••• In the CSV
29 Fluxunit - Osram Ventures Munich, Germany 19 3 3 •••@fluxunit.de +49896••• In the CSV
30 Henkel Ventures Düsseldorf, Germany Hardware Feelit 18 9 1 0049-2•••

Table 2. Corporate venture capital in DACH: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Boehringer Ingelheim Venture Fund Ingelheim Am Rhein, Germany 4 14 smartbax, xCures, Tacalyx
2 UBS Zürich, Switzerland 3 26 SWISSto12, MerQube, Nasdaq Private Market
3 Hitachi Ventures Munich, Germany 2 10 Thea Energy, Archetype AI
4 Leaps by Bayer Leverkusen, Germany 2 13 9amHealth, CORXEL Pharmaceuticals
5 Novartis Venture Fund Basel, Switzerland 2 20 Hepalink, FoRx Therapeutics
6 BASF Venture Capital Ludwigshafen, Germany 1 8 Computomics
7 Symbia VC Innsbruck, Austria 1 2 Strong by Form
8 Bosch Ventures Stuttgart, Germany 1 24 Point2 Technology
9 Bertelsmann Investments Gütersloh, Germany 1 6 QuantHealth
10 Archimedes New Ventures Bielefeld, Germany 1 2 Additive Marking
11 Nabtesco Technology Ventures Zürich, Switzerland 1 1 FOSSA Systems
12 Roche Venture Fund Basel, Switzerland 1 3 Cour Pharmaceuticals Development
13 Verbund X Ventures Vienna, Austria 1 2 SPiNE
14 Mücke Roth & Company Munich, Germany 1 4 Qdrant
15 Enpulse Stuttgart, Germany 1 1 Metiundo

Table 3. Corporate venture capital in DACH: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Thea Energy Thea Energy develops fusion energy technology to simplify the construction and operation of fusion power systems. Energy Kearny, United States Series B $20.0M 2026-08-18 $140.0M Hitachi Ventures 101 to 250 2022
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen, Germany Series B $7.3M 2026-08-18 $10.0M BASF Venture Capital 11 to 50 2012
Point2 Technology Point2 Technology develops dielectric waveguides for high-speed datacenter interconnects. Energy San Jose, United States Series B $80.0M 2026-08-10 $187.2M Bosch Ventures 51 to 100 2016
QuantHealth QuantHealth develops AI-powered clinical trial simulation software for pharmaceutical and biotechnology organizations. Artificial intelligence Tel Aviv, Israel Series B $45.0M 2026-08-04 $62.0M Bertelsmann Investments 101 to 250 2020
SWISSto12 SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. Hardware Renens, Switzerland Series C $70.0M 2026-07-16 $202.3M UBS 251 to 500 2011
smartbax Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. Biotech Munich, Germany Seed $5.5M 2026-06-30 $7.5M Boehringer Ingelheim Venture Fund 1 to 10 2021
FOSSA Systems FOSSA Systems develops satellite infrastructure and connectivity solutions for space-based communications. Hardware Madrid, Spain Series B $6.8M 2026-06-25 $7.7M Nabtesco Technology Ventures 51 to 100 2020
xCures xCures aggregates, organizes, and structures electronic medical records across multiple diseases and data types. Artificial intelligence Oakland, United States Series B $46.0M 2026-06-24 $59.0M Boehringer Ingelheim Venture Fund 11 to 50 2018
Cour Pharmaceuticals Development Cour Pharmaceuticals Development develops nanoparticle technology to reset immune systems in multiple sclerosis patients. Biotech Skokie, United States Series B $50.0M 2026-06-18 $185.5M Roche Venture Fund 51 to 100 2015
9amHealth 9amHealth offers a simplified approach to whole body health, including weight loss and diabetes management. Health care Encinitas, United States Series B $26.0M 2026-05-12 $55.2M Leaps by Bayer 251 to 500 2021

Table 4. Corporate venture capital in DACH: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 202 64%
Health care 72 23%
Artificial intelligence 71 23%
Hardware 57 18%
Biotech 53 17%
Fintech 52 17%
Commerce 26 8%
Energy 18 6%
Education 14 4%
Cybersecurity 10 3%

Table 5. Corporate venture capital in DACH: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Corporate venture capital in DACH by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
Germany 87 70%
Switzerland 30 24%
Austria 6 5%
Liechtenstein 1 1%

Table 7. Corporate venture capital in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Berlin 11 9%
Zürich 10 8%
Munich 9 7%
Stuttgart 7 6%
Frankfurt 5 4%
Vienna 4 3%
Düsseldorf 4 3%
Cologne 4 3%
Geneva 4 3%
Hamburg 4 3%
Basel 3 2%
Gütersloh 3 2%

Table 8. Corporate venture capital in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 15 13%
2010s 58 51%
2000s 14 12%
1990s 8 7%
1980s 1 1%
1970s 2 2%

Table 9. Corporate venture capital in DACH by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many corporate venture capital in DACH are on the list?
124, in the file dated 16 November 2026. 17 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
83 of the 124 carry an email address in the download and 60 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 124 rows, 83 firm email addresses and 60 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 56 of the 83 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Corporate venture capital in DACH: 124 rows, CSV, $29 one-time.

At once: the CSV with 124 rows, 83 firm email addresses and 60 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 56 of the 83 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other investors in DACH

Corporate venture capital elsewhere

Cite: FundingWatcher, 124 corporate venture capital in DACH, 16 November 2026. https://fundingwatcher.com/investors/corporate-venture-capital/dach/